Patients with end-stage heart failure have a much-improved option for left-ventricular support of the heart. The device, Heart Mate II, has a much smaller pump and is fully implantable within patient’s body regardless of patient’s chest cavity size.
Patients with end-stage heart failure now have a much-improved option for left-ventricular support of the heart. The new device, known as Heart Mate II has a much smaller pump, making it fully implantable within patient’s body regardless of patient’s chest cavity size. Hence, this is suitable for adults with smaller build, for example, Asians and female patients. The new device is also built to last, possibly for years. This means that the device can potentially be used for chronic long-term support of patients with irreversible heart failure.
Please click
here to read the media release.
